- In January 2024, Agilent Technologies announced the launch of ProteoAnalyzer system, an innovative automated parallel capillary electrophoresis system designed for protein analysis. This new platform enhances efficiency and simplifies the analysis of intricate protein mixtures, a crucial step in analytical workflows spanning the pharmaceutical, biotechnology, food analysis, and academic sectors
- In December 2023, Theralink Technologies announced groundbreaking research conducted by George Mason University and the University of California, San Francisco. This collaboration, stemming from the ISPY-2 trial, evaluated tumors from over 700 breast cancer patients using RPPA, revealing novel therapeutic avenues for some of the most daunting breast cancers that elude detection by existing diagnostic methods
- In September 2023, Yamaha Motor Co., Ltd. established Tuning Fork Bio Inc. in Delaware, USA, to analyze antibodies in blood for health visualization. Mainly targeting the U.S. and Japan, the company's antibody profiling aids in health checkups, drug selection, and pharmaceutical research
- In February 2023, Clinical diagnostics, the creation of vaccines, and the search for new medicines are only a few of the many applications supported by the core technique of recombinant protein production. High-throughput synthesis of correctly folded, functional, and complete proteins, however, is associated with a high failure rate. Protein misfolding might result in false positive results. For this reason, Sengenics KREXTM technology makes use of Biotin Carboxyl Carrier Protein (BCCP) as a solubility enhancer and folding marker
- In January 2022, In order to provide the SomaScan Proteomics Assay to Illumina's current and upcoming high-throughput next-generation sequencing (NGS) platforms, the companies inked a final co-development agreement. The high-throughput portion of the proteomics market, which is rapidly expanding, will benefit from this collaboration
